Article Sidebar

Published: 2026-07-06
Abstract Views: 16
DOI: https://doi.org/10.52163/yhc.v67iCD8.5659
Issue
Vol. 67 No. CĐ8-NCKH
Section
Articles
How to Cite
Tú, Đỗ Đình, Hương, Đỗ Q., Phương, V. T. B., & Châu, L. M. (2026). CLINICAL AND PARACLINICAL CHARACTERISTICS OF PATIENTS WITH GASTRIC AND DUODENAL ULCERS INFECTED WITH HELICOBACTER PYLORI AT THAI BINH UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL FROM JANUARY 2021 TO JUNE 2022. Vietnam Journal of Community Medicine, 67(CĐ8-NCKH). https://doi.org/10.52163/yhc.v67iCD8.5659

CLINICAL AND PARACLINICAL CHARACTERISTICS OF PATIENTS WITH GASTRIC AND DUODENAL ULCERS INFECTED WITH HELICOBACTER PYLORI AT THAI BINH UNIVERSITY OF MEDICINE AND PHARMACY HOSPITAL FROM JANUARY 2021 TO JUNE 2022

Do Dinh Tu1, Do Quoc Huong1, Vu Thi Binh Phuong1, Luu Minh Chau1
1 Thai Binh University of Medicine and Pharmacy

Main Article Content

Abstract

Objective: To describe the clinical and paraclinical characteristics of patients with gastric and duodenal ulcers infected with H.pylori participating in a study evaluating the effects of THV hard capsules at Thai Binh University of Medicine and Pharmacy Hospital.


Subjects and methods: A cross-sectional descriptive study combined with an interventional study was conducted on 102 patients with gastric and duodenal ulcers infected with H.pylori from January 2021 to June 2022. 52 patients participated in the study group (taking THV hard capsules) and 50 patients participated in the control group (taking Omeprazole combined with Metronidazole and Amoxicillin).


Results: The mean age of patients was 45.2 ± 12.3 in the intervention group and 46.3 ± 11.8 in the control group, the age group of 30-49 years accounted for the highest proportion, with 57.7% in the intervention group and 60% in the control group. Male patients accounted for 65.4% in the intervention group and 66% in the control group, higher than females in both groups, with statistically significant differences (p < 0.05). A total of 93.1% of patients had a single ulcer, and 81.4% had ulcers measuring 0.5-1.0 cm. All patients (100%) in both groups experienced epigastric pain, belching, and acid regurgitation. Superficial gastritis was observed in 42.3% of the intervention group and 46% of the control group.


Conclusion: Collecting clinical and paraclinical characteristics of patients, along with identifying risk factors, provides a scientific basis for appropriate and accurate evaluation and interpretation of intervention outcomes.

Article Details

Keywords

: Gastric and duodenal ulcers, Helicobacter pylori, THV hard capsules.

References

[1] Feldman M, Friedman L.S, Brandt L.J. Sleisenger and Fordtran’s gastrointestinal and liver disease e-book: pathophysiology, diagnosis, management. Elsevier Health Sciences, 2020.
[2] Narayanan M, Reddy K.M, Marsicano E. Peptic ulcer disease and Helicobacter pylori infection. Mo Med, 2018, 115 (3): 219-224.
[3] Hooi J.K.Y, Lai W.Y et al. Global prevalence of Helicobacter pylori infection: systematic review and meta-analysis. Gastroenterology, 2017, 153 (2): 420-429. doi: 10.1053/j.gastro.2017.04.022.
[4] Dang N.Q.H, Ha T.M.T, Nguyen S.T et al. High rates of Clarithromycin and levofloxacin resistance of Helicobacter pylori in patients with chronic gastritis in the south east area of Vietnam. J Glob Antimicrob Resist, 2020, 22: 620-624. doi: 10.1016/j.jgar.2020.06.007.
[5] Phan T.N, Santona A, Tran V.H et al. High rate of levofloxacin resistance in a background of Clarithromycin and Metronidazole-resistant Helicobacter pylori in Vietnam. Int J Antimicrob Agents, 2015, 45 (3): 244-248. doi: 10.1016/j.ijantimicag.2014.10.019.
[6] Salehi B, Sharopov F, Martorell M et al. Phytochemicals in Helicobacter pylori infections: What are we doing now? Int J Mol Sci, 2018, 19 (8): 2361. doi: 10.3390/ijms19082361.
[7] Phạm Bá Tuyến, Phạm Thị Hoa. So sánh hiệu quả điều trị loét hành tá tràng có nhiễm Helicobacter pylori bằng phác đồ HPMAX và phác đồ OAC. Published online September, 2013.
[8] Kim S.E, Memon A, Kim B.Y, Jeon H, Lee W.K, Kang S.C. Gastroprotective effect of phytoncide extract from Pinus koraiensis pinecone in Helicobacter pylori infection. Sci Rep, 2020, 10 (1): 9547. doi: 10.1038/s41598-020-66603-8.
[9] Phạm Thị Huệ, Nguyễn Thị Thanh Tú. Đặc điểm lâm sàng và cận lâm sàng bệnh nhân loét dạ dày tá tràng có Helocobacter pylori âm tính tại Bệnh viện Y học cổ truyền Hà Đông. Tạp chí Y học Việt Nam, 2022, 520 (1A): 30-33. doi: 10.51298/vmj.v520i1.3731.
[10] Lau J.Y, Sung J, Hill C, Henderson C, Howden C.W, Metz D.C. Systematic review of the epidemiology of complicated peptic ulcer disease: incidence, recurrence, risk factors and mortality. Digestion, 2011, 84 (2): 102-113. doi: 10.1159/000323958
[11] Đào Nguyên Khải và cộng sự. Nguyên nhân, mức độ và hình ảnh nội soi ở bệnh nhân loét dạ dày tá tràng có biến chứng chảy máu tiêu hóa. Tạp chí Y Dược lâm sàng 108, 2018, 13 (8): 31-37.
[12] Shim Y.K, Kim N. Nonsteroidal anti-inflammatory drug and Aspirin-induced peptic ulcer disease. Korean J Gastroenterol, 2016, 67 (6): 300-312. doi: 10.4166/kjg.2016.67.6.300
[13] Malik T.F, Gnanapandithan K, Singh K. Peptic ulcer disease, 2026. http://www.ncbi.nlm.nih.gov/books/NBK534792/
[14] Jung K, Moon W. Role of endoscopy in acute gastrointestinal bleeding in real clinical practice: an evidence-based review. World J Gastrointest Endosc, 2019, 11 (2): 68-83. doi: 10.4253/wjge.v11.i2.6